Accessibility Menu

Kobayashi Pharmaceutical(FRA) KOY

Market Cap€2.20BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPON/A
5 YearN/A
1 YearN/A
1 MonthN/A
€29.60
+0.00%
+0.00Today

Kobayashi Pharmaceutical Financials at a Glance

Market Cap

€2.20BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

€932.72

Net Income (TTM)

€9.80

EPS (TTM)

€0.13

P/E Ratio

225.95

Dividend

€0.57

Beta (Volatility)

0.02 (Low)

Price

€29.60

Volume

0

Open

€29.60

Previous Close

€29.60

Daily Range

€29.60 - €29.60

52-Week Range

€27.40 - €32.00

Estimated Earnings Date

N/A

KOY News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Kobayashi Pharmaceutical

Kobayashi Pharmaceutical Co., Ltd. engages in the manufacture and sale of over-the-counter (OTC) pharmaceuticals, quasi-drugs, air fresheners, and sanitary products. It operates through the following segments: Domestic, International, Mail Order, and Others. The Domestic segment manufactures and sells health care products, daily necessities, skin care products, and body warmers in Japan. The International segment sells beauty and health care products overseas. The Mail Order segment offers nutritional supplements and skin care products online. The Others segment includes transportation, synthetic resin container, advertising planning and production, insurance agency, and real estate businesses. The company was founded by Chubei Kobayashi in February 1886 and is headquartered in Osaka, Japan.

Industry

Personal Products

Sector

Consumer Staples

Employees

3,731

CEO

Norikaz Toyoda

Website

www.kobayashi.co.jp

KOY Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

82.76%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

0.44%

Dividend Yield

1.93%

Payout Ratio

N/A

Stock Overview

Market Cap

€2.20BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

74.34M

Volume

0

Avg. Volume

0.242

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Kobayashi Pharmaceutical Performance Analysis

Kobayashi Pharmaceutical annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31EUR 1,202,744,4780.6%
20232023-12-31EUR 1,141,010,041-5.1%
20242024-12-31EUR 1,010,553,222-11.4%
20252025-12-31EUR 981,681,998-2.9%
Kobayashi Pharmaceutical annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31EUR 1.88-3.4%
20232023-12-31EUR 1.76-6.1%
20242024-12-31EUR 0.83-53.2%
20252025-12-31EUR 0.29-64.8%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

€200.15

+0.9%

Gross Profit

€99.97

+0.9%

Gross Margin

49.95%

+1.0%

Market Cap

€2.20BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

€0.57

N/A

Employees

3,731

N/A

Net Income

€0.55

+0.1%

EBITDA

€17.91

+0.5%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

€277.27

-1.6%

Total Debt

€3.89

+0.9%

Accounts Receivable

€183.55

+0.9%

Inventory

€161.11

+0.9%

Long Term Debt

€2.43

+1.0%

Short Term Debt

€1.46

+0.7%

Return on Assets

67.41%

+0.1%

Return on Invested Capital

7.42%

+0.8%

Free Cash Flow

N/A

N/A

Operating Cash Flow

N/A

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,684.24-0.00%
^DJIDJI
$53,254.61-0.01%
^IXICNASDAQ
$26,319.55-0.00%
BTCBitcoin
$78,890.00-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.27-0.20%
NVDANvidia
$220.78+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.97+0.11%
CNHCNH Industrial
$11.83+0.01%

Questions About KOY

What is the current price of Kobayashi Pharmaceutical?

Kobayashi Pharmaceutical is trading at €29.60 per share.

What is the 52-week range for Kobayashi Pharmaceutical?

Over the past 52 weeks, Kobayashi Pharmaceutical has traded between €27.40 and €32.00.

How much debt does Kobayashi Pharmaceutical have?

As of the most recent reporting period, Kobayashi Pharmaceutical reported total debt of €3.89M.

How much cash does Kobayashi Pharmaceutical have on hand?

Kobayashi Pharmaceutical reported €273.37M in cash and cash equivalents in its most recent financial results.

What is Kobayashi Pharmaceutical’s dividend yield?

Kobayashi Pharmaceutical currently has a dividend yield of 1.93%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services